Cancer BiologybioRxivPreprint
FLT-PET as predictive non-invasive biomarker for neoadjuvant therapy with Wee1 and ATR inhibitors
Amirali B. Bukhari, Melinda Wuest, Frank R. Wuest, Armin M. Gamper
This study uses FLT-PET to predict response to DDR inhibitors in breast cancer models, finding early sequential PET can predict efficacy while initial uptake cannot.